Integrated FDG-PET-CT: its role in the assessment of bone and soft tissue tumors
- 28 July 2009
- journal article
- research article
- Published by Springer Nature in Archives of orthopaedic and trauma surgery
- Vol. 130 (7) , 819-827
Abstract
Purpose The purpose of this study was to evaluate prospectively, whether integrated 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography-computed tomography (FDG-PET-CT) is more accurate for determination musculoskeletal tumors compared with separate interpretation of CT and FDG-PET, because most of the current clinical data come from patients studied with PET. Methods Eighty patients with newly diagnosed musculoskeletal tumors underwent FDG-PET-CT. CT, FDG-PET, and FDG-PET-CT were interpreted separately to determine the performance of each imaging modality. Results Assuming that equivocal lesions are benign, performance of diagnostic tests was as follows: sensitivity, specificity and accuracy for CT alone was 81, 84, 83%, for PET 71, 82, 76, and for PET-CT 80, 83 and 86%. Assuming that equivocal lesions are malignant, sensitivity, specificity, and accuracy for CT was 61, 100, 70%, for PET 69, 100, 79, and for PET-CT 69, 100 and 79%. Conclusions Combined FDG-PET-CT reliably differentiates soft tissue and bone tumors from benign lesions. The value of the information provided by FDG-PET-CT for planning surgical procedures must be evaluated in further studies.Keywords
This publication has 29 references indexed in Scilit:
- Treatment Monitoring by 18F-FDG PET/CT in Patients with Sarcomas: Interobserver Variability of Quantitative Parameters in Treatment-Induced Changes in Histopathologically Responding and Nonresponding TumorsJournal of Nuclear Medicine, 2008
- F-18 FDG PET and PET/CT Evaluation of Response to Chemotherapy in Bone and Soft Tissue SarcomasClinical Nuclear Medicine, 2008
- Advances in Musculoskeletal Tumor ImagingOrthopedic Clinics of North America, 2006
- [18F]Fluorodeoxyglucose Positron Emission Tomography Predicts Outcome for Ewing Sarcoma Family of TumorsJournal of Clinical Oncology, 2005
- Prognostic Significance of Preoperative [18-F] Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) Imaging in Patients With Resectable Soft Tissue SarcomasAnnals of Surgery, 2005
- The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysisCancer Treatment Reviews, 2004
- Molecular imaging of cancer with positron emission tomographyNature Reviews Cancer, 2002
- Prospective evaluation of soft tissue masses and sarcomas using fluorodeoxyglucose positron emission tomographyBritish Journal of Surgery, 1999
- Grading Liposarcomas with PET using [18F]FDGJournal of Computer Assisted Tomography, 1990
- Adult Soft Tissue SarcomasAnnals of Surgery, 1987